Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
34
-
Total 13F shares, excl. options
-
1,347,068
-
Shares change
-
+541,460
-
Total reported value, excl. options
-
$14,634,326
-
Value change
-
+$5,581,826
-
Number of buys
-
19
-
Number of sells
-
-8
-
Price
-
$10.87
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q4 2015
37 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q4 2015.
XBiotech Inc. - Common Shares, no par value (XBIT) has 34 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1,347,068 shares
of 33,289,095 outstanding shares and own 4.05% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (482,518 shares), VANGUARD GROUP INC (364,612 shares), NORTHERN TRUST CORP (44,584 shares), ALPS ADVISORS INC (42,397 shares), OXFORD ASSET MANAGEMENT (42,282 shares), GEODE CAPITAL MANAGEMENT, LLC (40,531 shares), Nationwide Fund Advisors (38,369 shares), BlackRock Institutional Trust Company, N.A. (34,400 shares), M Holdings Securities, Inc. (26,833 shares), and ProShare Advisors LLC (26,468 shares).
This table shows the top 34 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.